Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to 15.64%.

  • Prestige Consumer Healthcare's EBITDA Margin fell 521.00% to 15.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.63%, marking a year-over-year decrease of 176.00%. This contributed to the annual value of 18.58% for FY2025, which is 24.00% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's EBITDA Margin stood at 15.64%, which was down 26.19% from 21.19% recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's EBITDA Margin ranged from a high of 21.40% in Q4 2023 and a low of -84.87% during Q1 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median EBITDA Margin value was 17.75% (recorded in 2025), while the average stood at 9.07%.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's EBITDA Margin crashed by 10,595bps in 2023, and later surged by 10,058bps in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EBITDA Margin (Quarterly) stood at 18.74% in 2021, then skyrocketed by 265bps to 21.39% in 2022, then climbed by 2bps to 21.40% in 2023, then tumbled by 507bps to 16.33% in 2024, then plummeted by 521bps to 15.64% in 2025.
  • Its EBITDA Margin was 15.64% in Q3 2025, compared to 21.19% in Q2 2025 and 17.75% in Q1 2025.